. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibiotics, Antineoplastic/administration & dosageAntibiotics, Antineoplastic/adverse effectsAntibiotics, Antineoplastic/therapeutic useDaunorubicin/administration & dosageDaunorubicin/adverse effectsDaunorubicin/therapeutic useDoxorubicin/administration & dosageDoxorubicin/therapeutic useDrug ApprovalDrug CarriersHIV Infections/complicationsHumansLiposomesSarcoma, Kaposi/drug therapySarcoma, Kaposi/etiologyUnited StatesUnited States Food and Drug Administration
Substances: See more » Antibiotics, AntineoplasticDrug CarriersLiposomesDoxorubicinDaunorubicin
Year: 1996 PMID: 11363485
Source DB: PubMed Journal: AIDS Treat News ISSN: 1052-4207